Skip to main content

Table 2 Association of CTCs/DTCs and clinicopathological datasets

From: Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis

 

No. of Studies (sample size)

OR (95 % CI)

Model

OR, p value

P-H

Begg’s test, p value

Serous carcinoma vs. Non-serous carcinoma

6 (789)

0.71 [0.49,1.05]

FE

0.0878

0.3876

0.719

FIGO stage III-IV vs. FIGO stage I-II

6 (687)

1.90 [1.02, 3.56]

FE

0.0438

0.0546

0.1361

Lymph node metastasis vs. No lymph node metastasis

3 (404)

1.14 [0.67, 1.93]

FE

0.6304

0.1484

1.0000

Suboptimal debulking vs. optimal debulking

2 (141)

0.78 [0.32, 1.88]

FE

0.5751

0.3232

1.0000

Platinum sensitive vs. Platinum resistant

2 (508)

0.55 [0.34, 0.90]

FE

0.0178

0.9298

1.0000

  1. FE Fixed-Effects; P-H P value –Heterogeneity